Navigation Links
United Therapeutics Corporation Reports 2010 Fourth Quarter and Annual Financial Results
Date:2/15/2011

ecember 31,Three Months EndedDecember 31,201020092008200720102009Net (loss) income, as reported

$

105,916$

19,462$

(49,327)$

12,353$

9,544$

(3,330)Add (subtract) non-cash charges:Interest expense

19,71412,87511,43914,2815,4593,659Income tax expense (benefit)

41,923(695)(34,394)(7,876)(5,039)(1,403)License fees

——150,000(1)

11,013(2)——Depreciation and amortization

17,92011,3944,5363,4273,7394,721Impairment charges

6,1775,4571,6053,5826,1775,058Share-based compensation

113,636100,81036,39348,76652,55827,502Earnings before non-cash charges

$

305,286$

149,303$

120,252$

85,546$

72,438$

36,207Earnings before non-cash charges per share:Basic

$

5.44$

2.80$

2.63$

1.98$

1.27$

0.67Diluted

$

5.13$

2.66$

2.41$

1.87$

1.17$

0.62Weighted average number of common shares outstanding:Basic56,14253,31445,80242,44857,18753,926Diluted59,51656,13349,90044,90261,71557,944(1) During the three months ended December 31, 2008, we made an upfront payment of $150.0 million to Eli Lilly and Company (Lilly) as required by our license and manufacturing and supply agreements. We also issued approximately 6.3 million shares of our common stock to Lilly in exchange for $150.0 million under a stock purchase agreement entered into together with the license and manufacturing and supply agreements. Because there was no net impact on our cash flows associated with these transactions, we have presented the related up-front payment as an adjustment to net loss.(2) During the year ended December 31, 2007, we issued 400,000 shares of our common stock to Toray Industries, Inc. The fair value of the shares issued was expensed as research and development.Conference CallWe will host a half-hour teleconference on Tuesday, Febr
'/>"/>

SOURCE United Therapeutics Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Baxter Announces Licensing Agreement for Innocolls Gentamicin Surgical Implant in the United States
2. InVitria Further Strengthens Sales Team with Promotion of Brandy Sargent to Account Manager - Western United States
3. JD Technologies, LLC Selected by FCT Ingenieurkeramik GmbH to Represent Their High Performance Ceramic Expertise In the United States
4. United Therapeutics to Announce Third Quarter 2008 Financial Results Before Market Open on Thursday, October 30, 2008
5. International Drug & Explosive Detection Firm Identa Corp Releasing: Jant Pharmacal Corporation Reports Successful Market Penetration of the Accutest(R) IDenta Co-brand in the United States and Oversees
6. Lilly Announces Launch of Color Differentiation System for Humalog(R) and Humulin(R) U-100 Insulin Products in the United States
7. Results of United Kingdom MRSA Surveillance Program Using Cepheid GeneXpert(R) System Demonstrate Benefits of Rapid Testing
8. Stallergenes: Launch of a Phase III Clinical Trial in Adults for Oralair(R) Grasses in the United States Operating Income Expected to Remain Stable in 2009
9. United Therapeutics Reports Third Quarter 2008 Financial Results
10. Lilly Contributes $11.1 Million to United Way Annual Campaign
11. First United Kingdom Patients Treated With Percutaneous MitraClip(R) System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... Minn. (PRWEB) March 05, 2015 Plant ... Pasadena this summer at the Annual Meeting of The ... starting to be released online now at APSnet.org/meet ... announced for the meeting, to be held August 1-5, ... announced Special Sessions, Field Trips, Workshops, and committee meetings, ...
(Date:3/5/2015)... 2015 Bi-Biomics today announced a ... stain additive. The improvement in histological quality provided ... present in all daughter cells. , After processing ... was analyzed at 1000-1600x using light microscopy. ... in all daughter cells displayed predominant binary features ...
(Date:3/5/2015)... TORONTO , March 5, 2015 /PRNewswire/ - Aptose Biosciences ... new therapeutics and molecular diagnostics that target the underlying ... Rice , Ph.D., Chairman, President and Chief Executive Officer, ... on Tuesday, March 10 th at 9:30 a.m. ... Niguel, CA. Dr. Rice will provide a ...
(Date:3/5/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/4ld5nw/mature_biotech ... Biotech Outlook 2015: New Therapy Ventures Pave the Way ... All biotech companies - Gilead (GILD), Amgen (AMGN), ... have given a positive return and hence increased the ... to select therapy/niche indication where the high treatment cost ...
Breaking Biology Technology:American Phytopathological Society Announces Annual Meeting Daily Schedule 2Aptose Biosciences to Present at the 27th Annual ROTH Conference 2Aptose Biosciences to Present at the 27th Annual ROTH Conference 3Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success 2Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success 3
... Even with radical advances in medicine and technology ... penile extender system is still the most effective ... QuickExtenderPro.com, the leading provider of penis extender ... With the emergence of the penile extender, procedures such ...
... Incorporated (Nasdaq: VPHM ) today announced that Vincent ... at the Leerink Swann Hot Topics in Therapeutics Roundtable Conference ... conference is being held at the Roosevelt Hotel in New ... for investors through www.viropharma.com and available for a ...
... ImmunGene, Inc., a privately held drug development company ... profile of the company and its interferon payload technology ... February 7 issue of BioCentury , one of ... biotech industries. ( www.biocentury.com ) The publication ...
Cached Biology Technology:QuickExtenderPro.com Penis Extender Device Engineered for Quick, Safe and Effective Alternative to Penis Enlargement Surgery 2ViroPharma to Participate in the Leerink Swann Hot Topics in Therapeutics Roundtable Conference 2ImmunGene's Interferon Payload Technology Platform Featured in BioCentury Magazine 2
(Date:2/13/2015)... , Feb. 13, 2015 ACT ... company that aims to transform cancer genomic information ... that the company has raised US$ 8 million in ... Based in Taipei, Taiwan , ... ACTDrug™, ACTOnco™. With the aim to implement next ...
(Date:2/10/2015)... WALTHAM, Mass., Feb. 10, 2015  Alere Inc. ... announced its financial results for the quarter ended ... Executive Officer and President of Alere said, "We ... refocussing Alere as the global leader in rapid ... closing the Alere Health divestiture in early January ...
(Date:2/5/2015)... , Jan. 26, 2015   Epic Sciences , a ... today announced that Murali Prahalad , Ph.D., president and ... World Conference (PMWC) 2015: Silicon Valley, which is taking ... View, Calif. on January 26-28, 2015. ... of Age as Biomarkers." Last year, Epic Sciences was a ...
Breaking Biology News(10 mins):ACT Genomics Raises $8 Million in its First Private Funding Round 2Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33Alere Inc. Announces Fourth Quarter 2014 Results 34Alere Inc. Announces Fourth Quarter 2014 Results 35
... new research published in a special issue of the ... to Seafood: Mercury Pollution in the Marine Environment" a ... Ecosystem Research Collaborative (C-MERC), scientists report that mercury released ... seafood commonly eaten by people in the U.S. and ...
... /PRNewswire-iReach/ -- As a technology capable of ... intelligent device capabilities and technology-embedded environments, Nanotechnology ... industries ranging from manufacturing, military, space exploration, ... already touched and improved virtually every area ...
... led by researchers at Harvard School of Public Health (HSPH) has ... life expectancy in 545 counties in the U.S. from 2000 to ... effects to public health of continuing to reduce air pollution levels ... 2012 online edition of the journal Epidemiology . "Despite ...
Cached Biology News:Mercury releases contaminate ocean fish: Dartmouth-led effort publishes major findings 2Mercury releases contaminate ocean fish: Dartmouth-led effort publishes major findings 3Mercury releases contaminate ocean fish: Dartmouth-led effort publishes major findings 4Global Market for Nanotechnology to Reach $3.3 Trillion by 2018 2Global Market for Nanotechnology to Reach $3.3 Trillion by 2018 3Declining air pollution levels continue to improve life expectancy in US 2
... Immunogen: Synthetic peptide derived from the ... 36 protein This peptide sequence is ... another Zymed polyclonal Connexin 36 antibody Cat. ... Connexin 36. Reactivity: Mouse (positive control: ...
Request Info...
...
...
Biology Products: